MUC16 and cancer: A-hundred-and-forty studies reported the detection potential of a single miRNA, and sixty-nine studies reported the potential of a panel of several miRNAs or a combination of a panel of miRNAs with cancer-specific protein-based biomarkers such as CA125 and HE4 (Table S1).